Mycophenolate mofetil and Lung abscess - a phase IV clinical study of FDA data

Summary:

Lung abscess is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 40-49 old, have been taking the drug for 10+ years also take Prednisone, and have Pemphigus.

The phase IV clinical study analyzes which people have Lung abscess when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Lung abscess?

Lung abscess (pus in lungs) is found to be associated with 290 drugs and 493 conditions by eHealthMe. Check the latest studies of Lung abscess.

On Aug, 08, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 78 people (0.08%) have Lung abscess.

Could Mycophenolate mofetil cause Lung abscess?

Among these 78 people:

How long have people been on Mycophenolate mofetil when they have Lung abscess? *

What is the gender of people who have Lung abscess when taking Mycophenolate mofetil? *

female: 23.81 %
male: 76.19 %

What is the age of people who have Lung abscess when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have besides Lung abscess? *

Pleural Effusion (water on the lungs): 20 people, 25.64%
Pneumonia: 20 people, 25.64%
Cytomegalovirus Infection: 19 people, 24.36%
Endocarditis (inflammation in heart muscle): 19 people, 24.36%
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 19 people, 24.36%
Fever: 17 people, 21.79%
Staphylococcal Infection (an infection with staphylococcus bacteria): 16 people, 20.51%
Encephalitis Fungal (inflammation of the brain due to fungal): 15 people, 19.23%
Bronchitis Bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection): 15 people, 19.23%
Oral Herpes (viral infection of mouth): 14 people, 17.95%

What are the existing conditions these people have? *

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 13 people, 16.67%
Immunodeficiency Disorders: 9 people, 11.54%
Pemphigoid (tense blisters on the skin): 9 people, 11.54%
High Blood Pressure: 7 people, 8.97%
Joint Pain: 5 people, 6.41%
Epstein-Barr Virus Associated Lymphoma (epstein-barr virus associated tumour): 4 people, 5.13%
Kidney Transplant Rejection: 3 people, 3.85%
Hodgkin's Disease Stage Iii (cancer originating from white blood cells - stage iii): 3 people, 3.85%
Transplant Rejection (a transplant material is not worked): 3 people, 3.85%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Lung abscess?

- Check whether Lung abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,461 reports)

Lung abscess treatments and more:

Lung abscess (2,845 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung abscess:

Lung abscess (290 drugs)

Browse all the conditions that are associated with Lung abscess:

Lung abscess (493 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.